The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2015
- Source ID
- 10.1016/j.bbmt.2015.05.010
Entities
People
- Alvaro Urbano-ispizua
- Ayman Saad
- Baldeep Wirk
- Bipin N Savani
- Christopher Dandoy
- Christopher N. Bredeson
- César O. Freytes
- David A. Rizzieri
- David G. Maloney
- David J. Inwards
- Gerard Socie
- Görgün Akpek
- Harry C. Schouten
- Henry C. Fung
- Hillard M Lazarus
- Jeanette Carreras
- John Gibson
- John P. Klein
- Lolie C. Yu
- Luciano J. Costa
- Mahmoud Aljurf
- Mary E. Flowers
- Mehdi Hamadani
- Mei-jie Zhang
- Miguel-Angel Perales
- Ran Reshef
- Reinhold Munker
- Richard F. Olsson
- Robert J. Hayashi
- Robert Peter Gale
- Rodrigo Martino
- Silvia Montoto
- Sonali M Smith
- Steven Z. Pavletic
- Taiga Nishihori
- Wael Saber
- Yoshihiro Inamoto
Organizations
- ARIAD Pharmaceuticals
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Health Research
- HistoGenetics (United States)
- Incyte
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)
- University of Minnesota
- University of Utah